week is also recommended. Aside from the benefits to breast cancer risk reduction, exercising also reduces the risk of heart disease (the #1 killer of all Americans), improves energy levels, and enhances self-esteem. Furthermore, exercise reduces the risk of breast cancer recurrence in breast cancer survivors by 30%.
Maintain Normal or Lean Body Weight --Lean women have significantly fewer breast cancers than obese women. The reason for this is that body fat produces estrogen, which increases the risk of developing breast cancer, especially in post-menopausal women. In addition, lean and moderately overweight women who exercised more than 75 minutes a
week have a 30% reduction in their risk of breast cancer. For a 200-pound woman, losing as little as 5-10% (10-20 pounds) of her body weight can significantly reduce her breast cancer risk.
Take Aspirin or Ibuprofen Regularly --Women who take 2 or more tablets of aspirin or ibuprofen each week for at least 5 years have a 20% lower risk of developing breast cancer.
Those who take these medications for more than 10 years lower their risk even further.
Regular use of ibuprofen reduces the risk by 50%. The best dose and frequency of use of aspirin or ibuprofen have not been determined. However, based on these initial findings, patients may consider taking a low dose of aspirin (81 mg) or ibuprofen (200 mg) twice a week if they are not already doing so for other reasons, and if there are no contraindications.
Avoid or Reduce Use of Hormone Replacement Therapy --For many years, hormone replacement therapy (HRT) has been recommended to post-menopausal women to improve heart health, prevent bone loss, and reduce hot flashes, vaginal dryness, or other symptoms of menopause. Numerous studies have evaluated the risk of breast cancer in women taking HRT. Unfortunately, the results of these studies were mixed, with some studies showing no increase in breast cancer risk and others showing modestly increased risk. Part of the reason for the controversy is that the studies all differed in important ways, such as in the type or dose of estrogen or progesterone, making it difficult to draw clear conclusions. Fortunately, a few helpful lessons did come out of those studies:
Combination HRT containing both progesterone and estrogen increases the risk of breast cancer when used for more than 5 years. Use for less than 5 years does not appear to increase breast cancer risk.
HRT containing estrogen alone has not been shown to increase the risk of breast cancer.
Estrogen-only HRT are used in women that have undergone hysterectomy.
HRT increases the density of the breast, making them firmer, lumpier, and harder to evaluate with mammography and physical examination. This can lead to delayed diagnosis or more frequent breast biopsies.
If you feel that combination HRT is necessary to help your patient maintain a sense of normalcy, then consider prescribing the lowest dose for the shortest period of time necessary to control her symptoms. If long term use of combination HRT is needed, then it is even more important for her to take measures to off-set the risk increase associated with the use of combination HRT.
Drink Less Alcohol --Daily alcohol consumption more than doubles the risk of breast cancer in women who have a mother, sister, or daughter with breast cancer. There is also slightly increased risk in women who have no family history of breast cancer. Therefore, it is recommended that women limit their alcohol consumption to no more than 1 serving per day (e.g., no more than one 12 ounce beer or 5 ounce glass of wine). Take Anti-Hormone Therapy --Anti-estrogen therapy significantly reduces the risk of breast cancer in women who are at increased risk. Tamoxifen (Nolvadex), raloxifene (Evista), and aromatase inhibitors are anti-estrogen drugs in common use today. Any of these medications can be taken daily for 5 years, but the breast cancer reduction benefit lasts even after the drugs have been stopped.
Avoid or Stop

High Risk Women
Although all women are at risk of developing breast cancer, women that carry a pathogenic genetic mutation related to breast cancer are at particularly high risk of developing breast cancer. In addition to practicing the usual risk reduction measures, women at high risk of breast cancer should consider additional strategies to further reduce their risk of developing breast cancer. The following risk reduction measures should be discussed with your patient:
Prophylactic Mastectomy --Prophylactic nipple sparing mastectomy or preventive removal of the breasts reduces the lifetime risk of breast cancer to less than 5% in women who have a high risk of breast cancer. This can be accompanied by breast reconstruction using implants or natural body tissues.
Bilateral Salpingo-oophorectomy -Bilateral salpingo-oophorectomy or removal of the fallopian tubes and ovaries in premenopausal women can reduce the risk of developing breast cancer by 50%.
Information is Empowering
By adopting these recommendations, your patients can reduce their chances of developing breast cancer, heart disease, lung cancers, and many other causes of premature death. But remember: early diagnosis is also essential! So, don't forget to have them obtain recommended breast cancer screening studies and annual physical examinations.
